ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

UHS vs JNJ // OPERATING MARGIN

Universal Health Services Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: UHS 6 — JNJ 7
▲ OPERATING MARGIN LEADER: JNJ
operating-margins
34.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC UHS JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.10% 25.50% -11.40 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 5.0x 18.5x -13.50 UHS /valuation <GO>
Free Cash Flow Yield 8.16% 2.97% +5.19 UHS /fcf-yield <GO>
Operating Margin ACTIVE 11.50% 34.70% -23.20 JNJ /operating-margins <GO>
Net Profit Margin 8.60% 28.50% -19.90 JNJ /net-margins <GO>
Revenue Growth (YoY) 9.70% 6.00% +3.70 UHS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.49% 0.00% +0.49 UHS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.11 5.59 -2.48 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 9/9 8/9 +1.00 UHS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.5 62.1 -15.60 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.04 1.08 -0.04 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 6.5x 23.0x -16.50 UHS /forward-pe <GO>
Enterprise Scale & Market Cap $10.41B $662.49B -$652.08B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR UHS REV JNJ REV UHS GROSS % JNJ GROSS % UHS FCF JNJ FCF
FY 2025 $17.36B $94.19B — 67.9% $849.2M $19.70B
FY 2024 $15.83B $88.82B — 69.1% $1.12B $19.84B
FY 2023 $14.28B $85.16B — — $625.1M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
JNJ // BETA 1.08